Product image of Beriate (Human Coagulation Factor Viii) supplied by GNH India

Beriate

Active Ingredient:
Human Coagulation Factor Viii
Origin:
EU

Beriate (Human Coagulation Factor Viii)

Beriate is a human coagulation factor VIII used to manage bleeding episodes in hemophilia A. This intravenous medication supports blood clotting for effective treatment.

Manufacturer / TM Owner

Csl Behring Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Beriate is primarily used to control and prevent bleeding in individuals with hemophilia A, a condition where the body lacks sufficient factor VIII. It is administered intravenously to help the blood clot properly, addressing bleeding episodes and supporting surgical procedures. The medication is tailored for those who require factor VIII replacement therapy.

Side Effects

  • Common effects of Beriate may include mild reactions at the injection site, such as redness or swelling. Some users might experience flu-like symptoms, including fever or chills. Severe allergic reactions are rare but possible and require immediate medical attention.

Precautions & Warnings

  • Beriate should be handled with care, ensuring proper storage and administration by trained healthcare professionals. Patients with known allergies to factor VIII or any components of the medication should avoid its use. Regular monitoring is advised to manage potential side effects and ensure the medication's effectiveness.

Avoid Interactions

  • Beriate may interact with certain medications, particularly those that affect blood clotting. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements. Alcohol and other substances that affect blood clotting should be used with caution.

Frequently Asked Questions

Beriate is used to manage and prevent bleeding episodes in individuals with hemophilia A by replacing the missing factor VIII.

Beriate is administered intravenously by a healthcare professional to ensure proper dosing and administration.

Common side effects may include mild reactions at the injection site, such as redness or swelling, and flu-like symptoms.

Yes, Beriate can be used to support blood clotting during surgical procedures in individuals with hemophilia A.

Individuals with known allergies to factor VIII or any components of Beriate should avoid its use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Viii

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT